Getting up to speed with the public health and regulatory challenges posed by new psychoactive substances in the information age
Authors:
Open Access
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findingsAddiction, 2012
- Commentary on Coulson & Caulkins (2012): Optimizing drug schedulingAddiction, 2012
- Scheduling of newly emerging drugs: a critical review of decisions over 40 yearsAddiction, 2012
- Cognitive and subjective effects of mephedrone and factors influencing use of a ‘new legal high’Addiction, 2012
- Mephedrone: use, subjective effects and health risksAddiction, 2011
- Legal highs and the challenges for policy makersAddiction, 2010
- WARNING: LEGAL SYNTHETIC CANNABINOID‐RECEPTOR AGONISTS SUCH AS JWH‐018 MAY PRECIPITATE PSYCHOSIS IN VULNERABLE INDIVIDUALSAddiction, 2010
- Mephedrone, new kid for the chop?Addiction, 2010
- How globalization and market innovation challenge how we think about and respond to drug use: ‘Spice’ a case studyAddiction, 2010
- DANGERS OF BANNING SPICE AND THE SYNTHETIC CANNABINOID AGONISTSAddiction, 2010